Quantum BioPharma Announces Peer-Reviewed Publication of Groundbreaking Clinical Trial for Unbuzzd
TORONTO, March 23, 2026 – Quantum BioPharma Ltd. (NASDAQ: QNTM), a biopharmaceutical company focused on innovative biotech solutions, has announced the peer-reviewed publication of a clinical trial for its dietary supplement product, Unbuzzd. The study, published in the World Journal of Pharmaceutical and Medical Research (2026, volume 12, issue 3), demonstrates significant effects on alcohol intoxication and metabolism.
Clinical Trial Design and Methodology
The double-blind, randomized, placebo-controlled crossover trial (NCT06505239) involved healthy male and female participants aged 21 to 43, with weights ranging from 119 to 232 pounds. Participants consumed alcohol to achieve a Blood Alcohol Concentration (BAC) between 0.07% and 0.11%, then ingested either Unbuzzd or a placebo. BAC, vital signs, and intoxication symptoms were monitored throughout the study.
Key Findings from the Study
The trial revealed several statistically significant outcomes compared to placebo:
- Accelerated Alcohol Metabolism: Unbuzzd dramatically reduced BAC levels, with metabolism rates over 40% faster within the first 30 minutes. This acceleration persisted over a four-hour period and was consistent across both genders.
- Rapid Improvements in Alertness: Participants reported enhanced alertness and fewer cognitive errors within 30 minutes of consuming Unbuzzd.
- Stabilized Physiologic Changes: The supplement lessened heart rate elevation and blood pressure drops associated with alcohol intoxication, stabilizing both parameters effectively.
- Reduced Perceived Impairment: Unbuzzd alleviated feelings of impairment and mental fatigue caused by alcohol consumption.
- Hangover Relief: Participants experienced a significant reduction in hangover symptoms, including a 67% decrease in headache severity at four hours, with benefits lasting up to eight hours.
- No Side Effects: Unbuzzd was well-tolerated by all participants, with no adverse effects reported.
Implications and Future Directions
This groundbreaking research highlights Unbuzzd's potential as a safe and effective solution for managing alcohol-related effects. The proprietary blend of vitamins and supplements, developed by Quantum BioPharma's scientific team, offers promising applications in health and wellness sectors. Further studies may explore its long-term benefits and broader consumer applications.
